Welcome to Medications.com
 

Fabrazyme Information

What's inside Fabrazyme

Fabrazyme Active Ingredients: agalsidase beta, details.
Fabrazyme Dosages & Strengths
Strength Format Route Strength Class
Fabrazyme 35 mg powder for injection intravenous 1.0 each OTC
Fabrazyme 5 mg powder for injection intravenous 1.0 each OTC

Fabrazyme in the News

Biotech Company Specializes In Treatments For Rare Disorders - CNNMoney.com
Genzyme also makes Fabrazyme, which generated $114 million in sales last quarter, up 18%, and $424 million for the year. The drug helps treat Fabry's ...
Wed Jan 23 20:12:43 +0000 2008

Fabry's drug outlook sinks Amicus shares - Trading Markets (press release)
s Fabrazyme. Shares plunged $5.59, or 37 percent, to close at $9.54 Thursday, having hit a new 52-week low of $9.20 earlier in the session. ...
Thu Dec 20 21:04:06 +0000 2007

Genzyme 'bullish' on future growth - Boston Globe
Fabrazyme, a treatment for Fabry disease, increased 18 percent to $114 million. Genzyme's drugs for rare hereditary disorders treat illnesses caused by a ...
Wed Jan 09 01:23:16 +0000 2008

Fabrazyme Chemical Information

agalsidase beta


© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea